Management of vaccine safety in Korea

about

Surveillance and compensation claims for adverse events following immunization from 2011 to 2016 in the Republic of Korea.

P2860

Q41221532-385CD57F-47A2-46BD-93D9-696E60708DC4

P2860

Management of vaccine safety in Korea

Item

http://www.wikidata.org/entity/Q36758046

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Management of vaccine safety in Korea

@ast

Management of vaccine safety in Korea

@en

type

Item

label

Management of vaccine safety in Korea

@ast

Management of vaccine safety in Korea

@en

prefLabel

Management of vaccine safety in Korea

@ast

Management of vaccine safety in Korea

@en

P1476

Management of vaccine safety in Korea

@en

P2093

Geun-Ryang Bae

http://www.w3.org/2001/XMLSchema#string

Young June Choe

http://www.w3.org/2001/XMLSchema#string

P2860

When science is not enough - a risk/benefit profile of thiomersal-containing vaccines

Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010.

No-fault compensation following adverse events attributed to vaccination: a review of international programmes.

Control of pertussis in the world.

Reactions of Norwegian children with severe egg allergy to an egg-containing influenza A (H1N1) vaccine: a retrospective audit.

Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations.

Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Advisory Committee on Causality Assessment.

Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.

Hypersensitivity reactions to vaccine constituents: a case series and review of the literature.

Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination.

P304

40-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7774/CEVR.2013.2.1.40

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236225837

http://www.w3.org/2001/XMLSchema#string

P698

23596589

http://www.w3.org/2001/XMLSchema#string

P932

3623500

http://www.w3.org/2001/XMLSchema#string

Management of vaccine safety in Korea

about

P2860

P2860

Management of vaccine safety in Korea

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932